Audit of timing of antibiotic prophylaxis in hip and knee arthroplasty

Journal of the Royal College of Surgeons of Edinburgh

Volumn 43, Issue 5, 1998, Pages 339-340

  Lewis, K ^a,b  

^a Cardiff Royal Infirmary   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Arthroplasty; Audit

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; TEICOPLANIN;

ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; DRUG DOSE; HIP ARTHROPLASTY; HUMAN; INFECTION RATE; INTRAVENOUS DRUG ADMINISTRATION; JOINT PROSTHESIS; KNEE ARTHROPLASTY; MEDICAL AUDIT; ORTHOPEDIC SURGERY; TIME;

ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CEFUROXIME; CEPHALOSPORINS; HUMANS; PREOPERATIVE CARE; TIME FACTORS;

EID: 0031668570     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Leach WJ, Wilson NIL. Trends in infection prophylaxis in orthopaedics. J Royal Coll Surg Edinb 1992; 37: 265-6.
2. Johnson DP, Bannister GC. The outcome of infected arthroplasty of the knee. JBJS 1986; 68B: 289-91.
3. Rand JA, Morrey JF, Bryan RS. Management of the total joint arthroplasty. Orthof Clin North Am 1984; 15 (3): 491-504.
4. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New Engl Med 1992; 326: 281-6.
5. Burke JF. The effective period of preventative antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.
6. Bowers WH, Wilson FC, Greene W. Antibiotic prophylaxis in experimental bone infections. JBJS 1973; 55A (4): 795-807.
7. Bannister G, Auchinloss J, Johnson D, Newman J. The timing of tourniquet application in relation to prophylactic antibiotic administration. JBJS 1988; 70B: 322-4.
8. Bannister G, Bitounis B, James T, Winson I, Watson N. The pharmacodynamics of prophylaxis in joint replacement. Acta Orthopaedica Hellenica 1989; 40 (2): 35-8.
9. Polk RE, Hepler CD. Controversies in antimicrobial therapy; critical analysis of clinical trials. Am J Hosp Pharmacy 1986; 43 (3): 630-40.
10. Lidwell O. The cost implications of clean air systems and antibiotic prophylaxis in operations for total replacement. Infection Control 1984; 5 (1): 36-7.
11. Suter F, Avai A, Fusco U, Gerundini M, Caprioli S, Maggiolo F. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994; 13(10): 793-6.
12. Periti P, Stringa G, Donati L, Mazzei T, Mini E, Novelli A. Teicoplanin - its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Eur J Surg Suppl 1992; 567: 3-8.
13. Tartaglione TA, Polk RE. Review of the new second generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Drug Intelligence Clin Pharmocol 1985; 19 (3): 188-98.